AmMax Bio, Inc.

Quick facts

Phase 2 pipeline

• AMB-05X · Autoimmune diseases
  AMB-05X is a small molecule inhibitor of the PI3K delta subunit.

Phase 1 pipeline

• AMG820 and pembrolizumab · Oncology
  AMG820 is a monoclonal antibody targeting CD28 and pembrolizumab is a monoclonal antibody targeting PD-1.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• AmMax Bio, Inc. portfolio CI brief
• AmMax Bio, Inc. pipeline updates RSS